Literature DB >> 9626998

Anti-CD3 activation of human CD4+ T cells increases expression of the intracellular beta-endorphin endopeptidase (IDE/gamma-EpGE).

B Sarada1, D Thiele, T Dang, J Lee, A Safavia, L B Hersh, G L Cottam.   

Abstract

In this study, increased expression of an endopeptidase hydrolyzing beta-endorphin (beta-Ep) to gamma-endorphin (gamma-Ep, beta-Ep1-17) was observed upon immobilized anti-CD3 stimulated activation of human peripheral blood CD4+ T cells (hCD4+ T cells). Although freshly isolated hCD4+ T cells are devoid of significant beta-Ep endopeptidase activity ( < 0.1 nmol h(-1) 10(6) cells (-1)), activation of these cells with immobilized anti-CD3 results in a time dependent appearance of beta-Ep endopeptidase activity which reaches a maximal value of 17.4+/-0.48 nmol h(-1) 10(6) cells(-1) after 48 h of culture. Significant up-regulation of both mRNA encoding IDE/gamma-EpGE and immunoreactive protein are observed in anti-CD3 stimulated hCD4+ T cells, indicating transcription and translation of IDE/gamma-EpGE may be elevated. No significant hydrolysis of exogenous beta-Ep is observed with intact hCD4+ T cells whether quiescent or activated or from preparations of hCD4+ T cell membranes. Therefore, this activity appears to be intracellular. Immunoreactive IDE/gamma-EpGE is detected inside activated hCD4+ T cells. Analysis of metabolites generated upon hydrolysis of beta-Ep with lysed activated hCD4+ T cell preparations identified the presence of: beta-Ep1-18, beta-Ep2-18, beta-Ep1-17, beta-Ep2-17, beta-Ep18-31, beta-Ep19-31, beta-Ep1-13, beta-Ep2-13, beta-Ep18-26, and beta-Ep20-31 as major metabolites and the majority of these are consistent with beta-Ep hydrolytic activity attributable to IDE/gamma-EpGE.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9626998     DOI: 10.1016/s0165-5728(97)00268-3

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  4 in total

1.  Suppression of CCL2/MCP-1 and CCL5/RANTES expression by nociceptin in human monocytes.

Authors:  David E Kaminsky; Thomas J Rogers
Journal:  J Neuroimmune Pharmacol       Date:  2007-09-15       Impact factor: 4.147

2.  Mammalian pitrilysin: substrate specificity and mitochondrial targeting.

Authors:  K Martin Chow; O Gakh; I C Payne; Maria Aparecida Juliano; Luiz Juliano; G Isaya; Louis B Hersh
Journal:  Biochemistry       Date:  2009-04-07       Impact factor: 3.162

3.  Beta-endorphin 1-31 biotransformation and cAMP modulation in inflammation.

Authors:  Naghmeh Hajarol Asvadi; Michael Morgan; Herath M Herath; Amitha K Hewavitharana; P Nicholas Shaw; Peter J Cabot
Journal:  PLoS One       Date:  2014-03-11       Impact factor: 3.240

4.  The N-Terminus of the HIV-1 p6 Gag Protein Regulates Susceptibility to Degradation by IDE.

Authors:  Adrian Schmalen; Julia Karius-Fischer; Pia Rauch; Christian Setz; Klaus Korn; Petra Henklein; Torgils Fossen; Ulrich Schubert
Journal:  Viruses       Date:  2018-12-12       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.